Japan expanded its export controls to include cutting-edge chips and quantum computer-related technology, a move China warned could have a negative impact on trade between the two countries.
If quantum is three to five years behind AI in technology development, is 2025 the equivalent of what 2022 was for AI?
Global Quantum Intelligence co-founder Doug Finke in an IBD interview talks about key developments for quantum computing stocks, including AI and cybersecurity.
Quantum computing has moved from theoretical concept to business reality, with corporations already implementing solutions and a growing quantum-as-a-service market
On the heels of some big quantum computing advances in 2024, at least one company is telling businesses to get “quantum ready” this year.
Being a quantum pioneer is turning out to be an expensive experiment. Quantum is still years away from widespread enterprise ROI.
Some of the moves could have major effects for climate change and climate technologies—for example, one of the first orders Trump signed signaled his intention to withdraw from the Paris Agreement, the major international climate treaty.
Quantum researchers have long believed that strong spin interactions in qubits required covalent bonds, making large-scale applications challenging. However, a new study proves that hydrogen bonds can effectively link spin centers,
Quantum computing has been on the horizon for what feels like decades. But with the explosion of artificial intelligence (AI) over the past year or so, the quantum computing future could be upon us. In 2025, there are several stocks that could benefit. Some are big tech businesses; others are specialty start-ups focused on a particular niche.
Researchers at the University of Oxford have pioneered a new approach to simulate turbulent systems, based on probabilities. The findings appear in the journal Science Advances.
Monday's tech sector meltdown, triggered by DeepSeek's AI breakthrough, caused collateral damage to share prices in the quantum computing space. When Nvidia plunged by 17% on fear
Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum computing and artificial intelligence to transform the drug discovery pipeline.